Search results
J&J hopes for deal with third talc settlement
BBC via AOL· 1 day ago[Getty Images] Johnson & Johnson has outlined a new settlement that it said would resolve nearly all of the lawsuits it faces over claims that its talc...
Wetzel Investment Advisors Inc. Invests $618,000 in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoWetzel Investment Advisors Inc. acquired a new position in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to the company in ...
Kornitzer Capital Management Inc. KS Trims Stock Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoKornitzer Capital Management Inc. KS lowered its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% in the fourth quarter, according to the ...
Johnson & Johnson Launches $6.48B Bankruptcy Plan to Resolve Talc Lawsuits | Law.com
Law.com· 1 day agoJohnson & Johnson announced plans for a subsidiary to file a third bankruptcy to resolve thousands...
Johnson & Johnson Proposes $6.5 Billion in New Talc Settlement Offer
New York Times· 1 day agoThe offer is the company’s third attempt to resolve tens of thousands of claims that its baby powder...
Company will pay $6.5 billion to settle talc ovarian cancer lawsuits
Medical Xpress· 13 hours agoJohnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25...
Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent:...
Simply Wall St. via Yahoo Finance· 4 days agoIt is hard to get excited after looking at Johnson & Johnson's (NYSE:JNJ) recent performance, when...
J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
WROC Rochester· 2 days agoA subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years...
Community Bank N.A. Has $6.75 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoCommunity Bank N.A. lessened its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.9% during the fourth quarter, according to the company in its ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 17 hours agoJohnson & Johnson company Janssen-Cilag International has filed applications with the European...